31Jan 2017

THE EFFECT OF DIABETES ON ACETOACETATE METABOLISM IN HEART.

Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background Aims: In this study, the effects of perfusion pressure, insulin, L-carnitine, propionate and 2,4-dinitrophenol on the utilization and oxidation of acetoacetate were investigated in the isolated non-working perfused heart from normal and diabetic rats. Materials and Method: Hearts from Male Wistar albino rats were used. In the diabetic subgroup, Diabetes was induced by an intravenous injection of alloxan. The hearts were perfused at a perfusion pressure of 40 or 80 mmHg for 1 h with Krebs-Henseleit Medium, with the concentrations of calcium and magnesium halved, and oxygenated by equilibration with 5% carbon dioxide and 95% oxygen. Determination of acetoacetate and D-3-hydroxybutyrate levels were made by the method of Mellanby and Williamson and Williamson and Mellanby respectively, and comparison between groups was done using the two-tailed Student’s t-test for independent samples. Results • Increasing Perfusion Pressure: No effect in both normal or diabetic hearts. • Insulin: No effect on acetoacetate utilization. • Diabetes: A decrease in the utilization and oxidation of acetoacetate and the production of D-3-hydroxybutyrate. • L- carnitine: o Normal hearts: no effect on acetoacetate utilization. o Diabetic hearts: acetoacetate utilization was enhanced • Propionate: o Normal hearts: Inhibited utilization of acetoacetate without affecting the rate of oxidation. The rate of D-3-hydroxybutyrate production was inhibited. o Diabetic hearts: Enhanced the utilization and oxidation of acetoacetate while reducing the production of D-3-Hydroxybutyrate • Dinitrophenol: o Normal hearts: Enhanced the utilization and oxidation of acetoacetate and decreased the production of D-3- hydroxybutyrate o Diabetic hearts: utilization and oxidation of acetoacetate were enhanced without effect on production of D-3- hydroxybutyrate. Conclusion: Diabetes inhibits and insulin has no significant effect on myocardial acetoacetate utilization and oxidation. Insulin, L-carnitine, or propionate are not suitable to ameliorate the utilization of acetoacetate in hearts from normal or diabetic animals, whereas Dinitrophenol enhances the catabolism of acetoacetate.

  1. Williamson, J. A. and Krebs, H. A., 1961, Acetoacetate as fuel of respiration in the perfused rat heart, Biochem. J., 80, 540-547.
  2. Hall, L. M., 1961, Preferential oxidation of acetoacetate by the perfused heart, Biochem. Biophys. Res. Commun., 6, 177-179.
  3. Taegtmeyer, H., Hems, R., and Krebs, H. A., 1980, Utilization of energy-providing substrates in the isolated working rat heart, Biochem. J., 186, 701-711.
  4. Janardhan, A., Chen, J., and Crawford, P. A. ,2011, Altered systemic ketone body metabolism in advanced heart failure, Tex. Heart Inst. J., 38 (5), 533-538.
  5. Sultan, A. M. N., 1992, Effects of diabetes and insulin on ketone bodies metabolism in heart, Mol. Cell. Biochem., 110, 17-23.
  6. Sultan, A. M. N., 1994, The effects of chronic diabetes and physiological insulin concentration on ketone bodies metabolism in the heart, Diabetes Research (Clinical and Experimental), 27, 47-60.
  7. Revsin-Lanier, B., Lebowitz, J., and Morrow, III G., 1980, Propionate enhancement of acetoacetate oxidation in perfused rat hearts, Clinical Sciences. 59, 289-292.
  8. Russell, R. R., and Taegtmeyer, H., 1991, Changes in citric acid cycle flux and anaplerosis antedate the functional decline in isolated rat hearts utilizing acetoacetate, J. Clin. Invest., 87, 384-390.
  9. Sultan, A. M. N., 1997, The effects of anaplerotic substrates on D-3-hydroxybutyrate metabolism in the heart, Mol. Cell. Biochem. 171, 59-64.
  10. Hulsmann, W. C., Siliprandi, D., Ciman, M., and Siliprandi, N., 1964, Effect of carnitine on the oxidation of a-oxoglutarate to succinate in the presence of acetoacetate or pyruvate, Biochem. Biophys. Acta., 93, 166-168.
  11. Bieber, L., Emaus, R., Valkner, K., and Farrell, S.,1982, Possible functions of short-chain and medium-chain carnitine acetyltransferase, Fed. Proc., 41, 2858-2862.
  12. Nosadini, R. Avogaro, A., Cobelli, C., Toffolo, G., Marescotti, C., Mollo, F., Benetton, M., Tiengo, A., and Enzi, G., 1984, The kinetics of ketone bodies in obese and insulin dependent diabetic subjects., In Recent Advances in Obesity and Diabetes Research. Melchionda, N. et al. Eds. Raven Press, New York, pp 293-307.
  13. Nosadini, R., Avogaro, A., Mollol, F., Marescotti, C., Tiengo, A., Siliprardi, N., Cobelli, C., and Toffolo, G. L., 1982, Carnitine improves acetoacetate disposal in insulin-dependent diabetic. In proceedings of the 11th IDF Meeting, 10-17 Nov. 1982, Nairobi, Kenya. Alberti KGMM et al. Eds. Excerpta Medica, Amsterdan, pp 123.
  14. Sultan, A. M. N., 2014, Utilization of D-3-hydroxybutyrate by the isolated perfused heart under global no-flow ischemia and stress conditions, UQU Med. J. 5 (1), 1-17.
  15. Schugar, R. C., Moll, A. R., d’Avignon D. A., Weinheimer, C. J., Kovacs, A., and Crawford, P. A., 2014, Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling,  Molecular Metabolism, 3, 754-769.
  16. Bedi Jr, K. C., Snyder N. W., Brandimarto, J., Aziz Moez, Mesaros, C., Worth, A. J., Wang, L. L., Javaheri, Ali, Blair ,I. A., Marglies, K. B., and Rame, J. E., 2016, Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation, 133, 706-716.
  17. Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., Koves, T., Gardell, S. J., Kruger, M., Hoppel, C. L., Lewandowski, E. D., Crawford, P. A., Muoio, D. M., and Kelly, D. P., 2016, The failing heart relies on ketone bodies as a fuel. Circulation, 133, 698-705.
  18. Kolwicz, Jr, S. C., Airhart, S., and Tian, R., 2016, Ketones step to the plate: A game changer for metabolic remodeling in heart failure. Circulation, 133, 689-691.
  19. Dedkova, E. N., and Blatter L. , 2014, Role of ?-hydroxybutyrate, its polymer poly- ?-hydroxybutyrate and inorganic polyphosphate in mammalian heath and disease, Frontiers in physiology, 5, 260, doci:10, 3389.
  20. Sultan, A. M. N., 1988, D-3-Hydroxybutyrate metabolism in the perfused rat heart, Mol. Cell. Biochem., 79, 113-118.
  21. Mellanby, J. and Williamson, D. H. Acetoacetate. In Methods of Enzymatic Analysis. Hans Ulrich Bergmeyer Ed. Academic Press, Vol.4, 1841-1843, 1974.
  22. Williamson, D. H. and Mellanby, J. D-(-)-3-Hydroxybutyrate. In Methods of Enzymatic Analysis. Hans Ulrich Bergmeyer Ed. Academic Press, Vol.4, 1836-1839, 1974.
  23. Krebs, H. A. and Henseleit, K., 1932, Untersuchungen uber die Harnstoffbildung im Tierkorper, Hoppe Seylers Z. Physiol. Chem., 210, 33-66.
  24. Sultan, A. M. N., 1990, The effect of fasting on D-3-hydroxybutyrate metabolism in the perfused rat heart, Mol. Cell. Biochem, 93, 107-118.
  25. Grinblat, L., Pacheco-Bolanos, L. F. and Stoppani, A. O. M., 1986, Decrease rate of ketone body oxidation and decreased activity of D-3-hydroxybutyrate dehydrogenase and succinyl-CoA : 3- oxoacid CoA - transferase in heart mitochondria of diabetic rats, Biochem. J., 240, 49-56.
  26. Yu-Yan Y., 1981, Antiketonemic and antiketogenic actions of carnitine in vivo and in vitro in rats, J. Nutr., 111, 831-840.
  27. Rodrigo, G. C., Lawrence, C. L., and Standen, N. B., 2002, Dinitrophenol pretreatment of rat ventricular myocytes protects against damage by metabolic inhibition and reperfusion, J. Mol. Cell. Cardiol., 34, 555-569.
  28. Hudman, D., Rainbow, R. D., Lawrence, C. L., and Standen, N. B., 2002, The origin of calcium overload in rat cardiac myocytes following metabolic inhibition with 2,4-dinitrophenol, J. Mol. Cardiol., 34, 859-871.
  29. Kang, S., Kim, N., Joo, H., Youm, J. B., Park W. S., Warda, M., Kim, H., Cuong, D. V., Kim, T., Kim, E., and Han, J., 2005, Changes of cytosolic Ca?² under metabolic inhibition in isolated rat ventricular myocytes, Korean J. Physiol. Pharmacol., 9, 291-298.
  30. Propionate caused a drastic reduction of free CoA and L-carnitinein heart, F.Di Lisa etd (1994).[31] Propionate on L-carnitine addition alone to acetoacetate had negligible effects on contact tile function Russell etd (1995).
  31. Pelletier, A., Joly, E., Prentki, M., and Coderre, L., 2005, Adenosine 5?-monophosphate-activated protein kinase and p38 mitogen-activated protein kinase participate in the stimulation of glucose uptake by dinitrophenol in adult cardiomyocytes, Endocrinology, 146, 2285-2294.

[Abdurazzaq M. N. Sultan, Daniya M. Alturkistani, Camellia A. Sultan, Nada A. Sagr, Heba A. Bargawi, Khulud K. Natto, Rabeea F. Farhan, Sultan A. Sultan, Abdulrahman A. Alghamdi, Qusai A. Sultan, Moayad. Filimban and Bayan H. Alghamdi. (2017); THE EFFECT OF DIABETES ON ACETOACETATE METABOLISM IN HEART. Int. J. of Adv. Res. 5 (Jan). 2877-2882] (ISSN 2320-5407). www.journalijar.com

Abdurazzaq M. N. Sultan
(Professor) Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University.

DOI:

Article DOI: 10.21474/IJAR01/3086      
DOI URL: https://dx.doi.org/10.21474/IJAR01/3086

Download Full Paper

Download PDF No. of Downloads: 39 | No. of Views: 189